In the present study, considering a relatively low percentage of Rh(D)-negative subjects in the Chinese population, which directly results in insufficient statistical power for the association between Rh blood group and the risk of NAFLD, we did not evaluate the combined effect of ABO and Rh blood groups on the risk of NAFLD. This evidence concerns the gene ABO and metabolic dysfunction-associated steatotic liver disease.